Britain has accepted a trade linked medicines pricing reset that makes the NHS pay more. NICE’s new chief executive has warned that paying more to satisfy Trump style demands is a huge backwards step because higher drug spend means higher taxes or NHS cuts. This analysis explains what the government agreed, why the policy is fracturing, and how the NHS cost can be estimated.
Cancer neuroscience shows that tumours do not just sit in the body. They recruit nerves, form synapses, steal mitochondria and tap into the stress system to grow and spread. Some of the most promising ways to interfere with that wiring involve cheap drugs we already have. The science is glamorous. The problem is simple. No one can make enough money from the obvious experiments.
A new daily pill called orforglipron promises to do for obesity and type two diabetes what Ozempic and Wegovy could never quite manage: escape the clinic and land in the bathroom cabinet. Trial data show close to ten per cent weight loss in people with diabetes and more in others, but also a harsher truth. This is not a cure. It is a lifelong metabolic lease.
President Donald J. Trump delivered what he described as “the biggest medical announcement in U.S. history,” linking the use of paracetamol (known in the United States under the brand name Tylenol) to autism risk...
She remembers the knock on the door like it was yesterday. The sheriff’s deputy, the sealed envelope, the word she’d been dreading: lawsuit. Her son was gone, another casualty in the long tail of...
For decades, cancer was understood as a disease of rogue cells, growing uncontrollably, feeding themselves through blood vessels and oxygen supplies. But a wave of discoveries is reshaping that picture, and with it, the...